151 related articles for article (PubMed ID: 37592900)
1. An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective.
Makiyama J; Ishitsuka K; Munakata W; Maruyama D; Nagai H
Jpn J Clin Oncol; 2023 Dec; 53(12):1104-1111. PubMed ID: 37592900
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.
Katsuya H
Int J Hematol; 2023 Apr; 117(4):512-522. PubMed ID: 36862273
[TBL] [Abstract][Full Text] [Related]
3. [Adult T-cell leukemia/lymphoma].
Yoshimitsu M
Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of adult T-cell leukemia/lymphoma.
Ishitsuka K
Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with brentuximab vedotin for relapsed and refractory adult T cell leukemia.
Oka S; Ono K; Nohgawa M
Anticancer Drugs; 2020 Jun; 31(5):536-539. PubMed ID: 31934889
[TBL] [Abstract][Full Text] [Related]
6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
7. [Development of future treatment for ATL].
Ishitsuka K
Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
[TBL] [Abstract][Full Text] [Related]
8. Successful Treatment of an Aggressive Adult T-cell Leukemia/Lymphoma with Strong CD30 Expression Using Brentuximab Vedotin as Combination and Maintenance Therapy.
Baba Y; Sakai H; Kabasawa N; Harada H
Intern Med; 2023 Feb; 62(4):613-616. PubMed ID: 35871596
[TBL] [Abstract][Full Text] [Related]
9. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H; Ishitsuka K
J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.
Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A
Front Microbiol; 2020; 11():1207. PubMed ID: 32636814
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
[TBL] [Abstract][Full Text] [Related]
12. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
O'Connor OA; Lue JK; Sawas A; Amengual JE; Deng C; Kalac M; Falchi L; Marchi E; Turenne I; Lichtenstein R; Rojas C; Francescone M; Schwartz L; Cheng B; Savage KJ; Villa D; Crump M; Prica A; Kukreti V; Cremers S; Connors JM; Kuruvilla J
Lancet Oncol; 2018 Feb; 19(2):257-266. PubMed ID: 29276022
[TBL] [Abstract][Full Text] [Related]
13. Adult T-Cell Leukemia/Lymphoma.
Mehta-Shah N; Ratner L; Horwitz SM
J Oncol Pract; 2017 Aug; 13(8):487-492. PubMed ID: 28796966
[TBL] [Abstract][Full Text] [Related]
14. Adult T-cell leukemia-lymphoma.
Tsukasaki K
Hematology; 2012 Apr; 17 Suppl 1():S32-5. PubMed ID: 22507774
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
[TBL] [Abstract][Full Text] [Related]
17. Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure.
Ueda N; Kato H; Kato S; Saito T; Tachibana H; Yanada M; Taji H; Kodaira T; Hosoda W; Yamamoto K
Hematology; 2023 Dec; 28(1):2207946. PubMed ID: 37183912
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options for adult T-cell leukemia/lymphoma.
Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma.
Ishizawa K; Yanai T
Adv Ther; 2019 Oct; 36(10):2679-2696. PubMed ID: 31392578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]